hyperthermic intraperitoneal chemotherapy
Jump to navigation
Jump to search
Indications
- ovarian cancer (option)
- colorectal cancer (indication less clear)[2][3]
More general terms
References
- ↑ van Driel WJ, Koole SN, Sikorska K. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med 2018; 378:230-240. January 18, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29342393 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1708618
- ↑ 2.0 2.1 van Stein RM, Aalbers AGJ, Sonke GS et al Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer. A Review. JAMA Oncol. 2021;7(8):1231-1238. May 6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33956063 https://jamanetwork.com/journals/jamaoncology/fullarticle/2779523
- ↑ 3.0 3.1 Arjona-Sanchez A, Espinosa-Redondo E, Gutierrez-Calvo A et al Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer. A Phase 3 Randomized Clinical Trial. JAMA Surg. 2023;158(7):683-691 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37099280 PMCID: PMC10134040 (available on 2024-04-26) https://jamanetwork.com/journals/jamasurgery/fullarticle/2804110